ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank93
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$105.15M
↑ 216% vs avg
Percentile
P93
Near historical high
Streak
1 yr
Consecutive declineContracting
Average
$-90.60M
Historical baseline
PeriodValueYoY Change
TTM$105.15M-33.1%
2024$157.20M+773.3%
2023$-23.35M+79.5%
2022$-114.03M+10.1%
2021$-126.78M+11.8%
2020$-143.75M+5.6%
2019$-152.26M+10.2%
2018$-169.62M+22.4%
2017$-218.67M+0.6%
2016$-219.91M-